OPKO Health Total Liabilities 2010-2023 | OPK

OPKO Health total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.885B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.482B 26.59
Intuitive Surgical (ISRG) United States $131.844B 79.42
Edwards Lifesciences (EW) United States $50.799B 33.06
DexCom (DXCM) United States $50.060B 75.83
IQVIA Holdings (IQV) United States $42.279B 25.07
IDEXX Laboratories (IDXX) United States $38.873B 45.31
Alcon (ALC) Switzerland $38.723B 28.56
STERIS (STE) Ireland $20.261B 23.98
Waters (WAT) United States $18.737B 26.89
Hologic (HOLX) United States $17.905B 19.76
SONOVA HOLDING (SONVY) Switzerland $16.708B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.452B 15.38
ShockWave Medical (SWAV) United States $12.372B 85.23
Sysmex ADR (SSMXY) Japan $10.492B 32.90
Teleflex (TFX) United States $9.964B 15.65
Penumbra (PEN) United States $7.957B 98.22
Masimo (MASI) United States $7.091B 39.77
Globus Medical (GMED) United States $6.827B 21.64
Glaukos (GKOS) United States $4.964B 0.00
TransMedics (TMDX) United States $3.847B 367.50
Integer Holdings (ITGR) United States $3.678B 22.22
LivaNova (LIVN) United Kingdom $3.391B 20.14
PROCEPT BioRobotics (PRCT) United States $3.115B 0.00
Elekta AB (EKTAY) Sweden $2.700B 18.52
Nihon Kohden (NHNKY) Japan $2.423B 20.49
Inari Medical (NARI) United States $2.419B 0.00
Tandem Diabetes Care (TNDM) United States $2.337B 0.00
Integra LifeSciences Holdings (IART) United States $2.294B 9.41
RxSight (RXST) United States $2.108B 0.00
Alphatec Holdings (ATEC) United States $1.813B 0.00
Veracyte (VCYT) United States $1.539B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.868B 16.06
Artivion (AORT) United States $0.838B 96.81
Paragon 28 (FNA) United States $0.817B 0.00
Silk Road Medical (SILK) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.738B 0.00
Treace Medical Concepts (TMCI) United States $0.671B 0.00
SiBone (SIBN) United States $0.598B 0.00
Mesa Laboratories (MLAB) United States $0.594B 20.18
IRadimed (IRMD) United States $0.532B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.487B 0.00
Pacific Biosciences Of California (PACB) United States $0.460B 0.00
Pulse Biosciences (PLSE) United States $0.420B 0.00
NeuroPace (NPCE) United States $0.401B 0.00
Nevro (NVRO) United States $0.382B 0.00
Tactile Systems Technology (TCMD) United States $0.341B 11.47
AxoGen (AXGN) United States $0.287B 0.00
Sight Sciences (SGHT) United States $0.277B 0.00
EDAP TMS S.A (EDAP) France $0.263B 0.00
AngioDynamics (ANGO) United States $0.232B 0.00
CVRx (CVRX) United States $0.219B 0.00
Accuray (ARAY) United States $0.215B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
908 Devices (MASS) United States $0.187B 0.00
Semler Scientific (SMLR) United States $0.184B 9.90
Alpha Tau Medical (DRTS) Israel $0.169B 0.00
Inogen (INGN) United States $0.166B 0.00
Delcath Systems (DCTH) United States $0.150B 0.00
ClearPoint Neuro (CLPT) United States $0.147B 0.00
Neuronetics (STIM) United States $0.107B 0.00
KORU Medical Systems (KRMD) United States $0.103B 0.00
Spectral Diagnostics (EDTXF) Canada $0.095B 0.00
Envoy Medical (COCH) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.068B 0.00
Autonomix Medical (AMIX) United States $0.063B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
Sensus Healthcare (SRTS) United States $0.059B 120.33
SEP Acquisition (SEPA) United States $0.058B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Yubo Biotech (YBGJ) China $0.053B 0.00
Vasomedical (VASO) United States $0.050B 9.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
InspireMD (NSPR) Israel $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.044B 0.00
DarioHealth (DRIO) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
LENSAR (LNSR) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.025B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
PAVmed (PAVM) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00